| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.44 | 0.001 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.005 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |